non-small cell lung cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (65)

Phase 1 (11)
Phase 1/2 (10)
Phase 2 (22)
Phase 3 (9)
Phase 4 (1)
Unknown (13)

Interventional (56)
Observational (8)
INTERVENTIONAL (1)

Fudan University (3)
Hoffmann-La Roche (3)
BeiGene (2)
M.D. Anderson Cancer Center (2)
National Cancer Institute (NCI) (2)
Sanofi (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
Sun Yat-sen University (2)
AIO-Studien-gGmbH (1)
AbbVie (1)
Affimed GmbH (1)
Arcus Biosciences, Inc. (1)
Ascentage Pharma Group Inc. (1)
AstraZeneca (1)
Atreca, Inc. (1)
Beijing Pearl Biotechnology Limited Liability Company (1)
Blueprint Medicines Corporation (1)
Calithera Biosciences, Inc (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
City of Hope Medical Center (1)
Emory University (1)
European Lung Cancer Working Party (1)
Fundación GECP (1)
Gan and Lee Pharmaceuticals, USA (1)
Genentech, Inc. (1)
Guangdong Association of Clinical Trials (1)
Guangzhou Institute of Respiratory Disease (1)
Gustave Roussy, Cancer Campus, Grand Paris (1)
Hospital Israelita Albert Einstein (1)
Icahn School of Medicine at Mount Sinai (1)
Istituto Clinico Humanitas (1)
JS InnoPharm, LLC (1)
Karyopharm Therapeutics Inc (1)
Massachusetts General Hospital (1)
Memorial Sloan Kettering Cancer Center (1)
Merck Sharp & Dohme Corp. (1)
Mersana Therapeutics (1)
National Hospital Organization Nagoya Medical Center (1)
Oslo University Hospital (1)
Papworth Hospital NHS Foundation Trust (1)
Regeneron Pharmaceuticals (1)
Scott R. Plotkin, MD, PhD (1)
Seattle Genetics, Inc. (1)
ShangHai HaiHe Pharmaceutical (1)
Shanghai JMT-Bio Inc. (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)
Spectrum Pharmaceuticals, Inc (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
Swiss Group for Clinical Cancer Research (1)
The Netherlands Cancer Institute (1)
The University of Hong Kong (1)
Universitaire Ziekenhuizen Leuven (1)
Vyriad, Inc. (1)
Wake Forest University Health Sciences (1)
Yuhan Corporation (1)

No (66)

No (65)
Yes (1)

Adult (18+) (66)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadnon-small cell lung cancer

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadmetastasis

I am/have/hadtyrosine

I am/have/hadalopecia

I am/have/hadsolid tumour

I am/have/hadgilbert's syndrome

I am/have/hadsecondary malignant neoplasm of liver

I am/have/hadbrain metastases

I am/have/hadneutrophil count

I am/have/hadbrain metastasis

I am/have/hadcancer chemotherapy

I am/have/hadchemoradiotherapy

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadhair thinning

I am/have/hadplatelet count

added new label for I am/have/had

more

I am looking for

I am looking forpemetrexed

I am looking forcarboplatin

I am looking forgefitinib

I am looking forcisplatin

I am looking forepidermal growth factor

I am looking forpaclitaxel

I am looking fordocetaxel

I am looking fortyrosine

I am looking forgrowth factor

I am looking forpembrolizumab

I am looking forgemcitabine

I am looking forplatinum doublet

I am looking forkinase inhibitor

I am looking foradjuvant

I am looking forplatinum-based chemotherapy

I am looking forosimertinib

I am looking forcrizotinib

I am looking formelanoma

I am looking forkras

I am looking fornivolumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1751 clinical trials

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Endocrinology
Recruiting

CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC

Besides, response and long term clinical benefit of immunotherapy of advanced NSCLC lung cancer patients could also be predicted by this strategy.

ct scan

ct scan chest

lung cancer

cancer

adenocarcinoma

0 views
05 Aug, 2020

171
172
173
174
175
176

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.